The Long Run with Luke Timmerman
Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases
August 11, 2026·1h 17m
Episode Description from the Publisher
Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs based on human genetics for kidney diseases.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
September 9, 2026·1h 36m
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
August 25, 2026·1h 7m
Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases
July 28, 2026·1h 7m
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
July 14, 2026·1h 8m
Get summaries like this every morning.
Free AI-powered recaps of The Long Run with Luke Timmerman and your other favorite podcasts, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.